Cancer, including Prostate, Colorectal and Lung

From the advanced search, you can use the IDs below to search within the topic "Cancer, including Prostate, Colorectal and Lung" (whose ID is 46), by searching on (46/0) [cluster] (replacing the "46/0" with any cluster id below)

ID	Cluster Name Click to Search	Defining Terms
46/0	Cancer, including Prostate, Colorectal and Lung sub-cluster 0	tamoxifen breast cancer aromatase adjuvant postmenopausal women anastrozole therapy letrozole
46/1	Cancer, including Prostate, Colorectal and Lung sub-cluster 1	psa prostate cancer biopsy men ng patients antigen ml gleason
46/2	Cancer, including Prostate, Colorectal and Lung sub-cluster 2	colorectal screening cancer colonoscopy occult sigmoidoscopy polyps fecal crc fobt
46/3	Cancer, including Prostate, Colorectal and Lung sub-cluster 3	adjuvant cancer breast chemotherapy therapy treatment trials colorectal patients colon
46/4	Cancer, including Prostate, Colorectal and Lung sub-cluster 4	pancreatic cancer pancreatitis patients pancreas gemcitabine cancers diagnosis treatment risk
46/5	Cancer, including Prostate, Colorectal and Lung sub-cluster 5	cervical cancer screening women pap invasive smear cytology smears treatment
46/6	Cancer, including Prostate, Colorectal and Lung sub-cluster 6	elderly cancer patients older breast treatment age geriatric chemotherapy lung
46/7	Cancer, including Prostate, Colorectal and Lung sub-cluster 7	screening cancer breast screen cancers women mortality cost detection programme
46/8	Cancer, including Prostate, Colorectal and Lung sub-cluster 8	hpv cancer cervical papillomavirus cancers human screening infection risk women
46/9	Cancer, including Prostate, Colorectal and Lung sub-cluster 9	prostate cancer men screening treatment risk disease patients psa diagnosed
46/10	Cancer, including Prostate, Colorectal and Lung sub-cluster 10	endometrial cancer tamoxifen women cancers patients risk endometrium uterine estrogen
46/11	Cancer, including Prostate, Colorectal and Lung sub-cluster 11	androgen prostate cancer ar deprivation therapy androgens treatment advanced patients
46/12	Cancer, including Prostate, Colorectal and Lung sub-cluster 12	neck head cancer patients cancers treatment chemotherapy radiotherapy therapy advanced
46/13	Cancer, including Prostate, Colorectal and Lung sub-cluster 13	lung cancer small cell chemotherapy nsclc patients advanced sclc treatment
46/14	Cancer, including Prostate, Colorectal and Lung sub-cluster 14	gastric cancer patients cancers early gastrectomy advanced endoscopic resection ulcer
46/15	Cancer, including Prostate, Colorectal and Lung sub-cluster 15	ovarian cancer chemotherapy epithelial women patients advanced cancers screening treatment
46/16	Cancer, including Prostate, Colorectal and Lung sub-cluster 16	cancer family familial history families breast risk colorectal relatives cancers
46/17	Cancer, including Prostate, Colorectal and Lung sub-cluster 17	colorectal cancer hereditary hnpcc msi nonpolyposis microsatellite cancers polyposis instability
46/18	Cancer, including Prostate, Colorectal and Lung sub-cluster 18	bladder cancer urinary superficial cystectomy patients invasive intravesical urine bcg
46/19	Cancer, including Prostate, Colorectal and Lung sub-cluster 19	estrogen cancer breast hrt estrogens replacement therapy risk women hormone
46/20	Cancer, including Prostate, Colorectal and Lung sub-cluster 20	mammography breast cancer screening women mammographic cancers mammograms detection biopsy
46/21	Cancer, including Prostate, Colorectal and Lung sub-cluster 21	cancer hormone hormonal breast therapy prostate hormones treatment advanced replacement
46/22	Cancer, including Prostate, Colorectal and Lung sub-cluster 22	node lymph cancer sentinel nodes breast axillary dissection sln patients
46/23	Cancer, including Prostate, Colorectal and Lung sub-cluster 23	cancer breast brca1 genetic brca2 mutation genetics ovarian risk testing
46/24	Cancer, including Prostate, Colorectal and Lung sub-cluster 24	pet cancer fdg tomography positron emission staging ct lung imaging
46/25	Cancer, including Prostate, Colorectal and Lung sub-cluster 25	cancer sir cancers incidence risk ci hodgkin cohort patients sirs
46/26	Cancer, including Prostate, Colorectal and Lung sub-cluster 26	cancer smoking lung tobacco cigarette alcohol risk smokers cancers smoke
46/27	Cancer, including Prostate, Colorectal and Lung sub-cluster 27	esophageal cancer esophagus barrett endoscopic patients dysplasia cancers therapy adenocarcinoma
46/28	Cancer, including Prostate, Colorectal and Lung sub-cluster 28	prostatectomy radical prostate cancer surgery patients gleason localized treatment men
46/29	Cancer, including Prostate, Colorectal and Lung sub-cluster 29	er breast cancer estrogen receptor her2 pr oestrogen status positive
46/30	Cancer, including Prostate, Colorectal and Lung sub-cluster 30	cancer childhood survivors cancers term treatment long survivor late children
46/31	Cancer, including Prostate, Colorectal and Lung sub-cluster 31	colorectal cancer patients risk cancers advanced treatment metastatic surgery prevention
46/32	Cancer, including Prostate, Colorectal and Lung sub-cluster 32	rectal cancer surgery resection patients local excision radiotherapy preoperative colorectal
46/33	Cancer, including Prostate, Colorectal and Lung sub-cluster 33	radiation cancer therapy treatment breast dose cancers risk patients prostate
46/34	Cancer, including Prostate, Colorectal and Lung sub-cluster 34	chemotherapy cancer breast patients treatment nausea advanced clinical vomiting agents
46/35	Cancer, including Prostate, Colorectal and Lung sub-cluster 35	pylori cancer gastric helicobacter infection gastritis patients infections risk eradication
46/36	Cancer, including Prostate, Colorectal and Lung sub-cluster 36	qol cancer quality life patients scale breast eortc questionnaire validity
46/37	Cancer, including Prostate, Colorectal and Lung sub-cluster 37	radiotherapy cancer breast treatment prostate imrt patients radiation chemotherapy dose
46/38	Cancer, including Prostate, Colorectal and Lung sub-cluster 38	lung cancer screening patients diagnosis cancers early risk ct detection
46/39	Cancer, including Prostate, Colorectal and Lung sub-cluster 39	egfr cancer growth igf epidermal factor receptor breast colorectal lung
46/40	Cancer, including Prostate, Colorectal and Lung sub-cluster 40	cancer polymorphism risk genotype lung breast allele genotypes colorectal ci
46/41	Cancer, including Prostate, Colorectal and Lung sub-cluster 41	occupational cancer occupation exposure risk occupations industry cancers workers exposures
46/42	Cancer, including Prostate, Colorectal and Lung sub-cluster 42	prostate cancer prostatic treatment patients benign risk therapy advanced hyperplasia
46/43	Cancer, including Prostate, Colorectal and Lung sub-cluster 43	cancer vitamin dietary risk intake diet carotene prevention fat breast
46/44	Cancer, including Prostate, Colorectal and Lung sub-cluster 44	cancer life quality fatigue patients treatment breast anemia related symptoms
46/45	Cancer, including Prostate, Colorectal and Lung sub-cluster 45	chemoprevention cancer agents chemopreventive prevention carcinogenesis retinoids trials tea chemotherapeutic
46/46	Cancer, including Prostate, Colorectal and Lung sub-cluster 46	thyroid cancer patients cancers differentiated papillary radioiodine treatment iodine management
46/47	Cancer, including Prostate, Colorectal and Lung sub-cluster 47	cox-2 cancer angiogenesis inhibitors vegf colorectal nsaids angiogenic anti growth
46/48	Cancer, including Prostate, Colorectal and Lung sub-cluster 48	cancer ci risk rr breast cancers colorectal patients confidence prostate
46/49	Cancer, including Prostate, Colorectal and Lung sub-cluster 49	breast mastectomy cancer reconstruction patients surgery radical flap recurrence nipple
46/50	Cancer, including Prostate, Colorectal and Lung sub-cluster 50	mortality cancer trends rates cancers lung incidence breast countries age
46/51	Cancer, including Prostate, Colorectal and Lung sub-cluster 51	surgical cancer treatment breast management lung resection patients surgery cancers
46/52	Cancer, including Prostate, Colorectal and Lung sub-cluster 52	cancer cam pdt complementary medicine alternative photodynamic therapies patients therapy
46/53	Cancer, including Prostate, Colorectal and Lung sub-cluster 53	cancer workers mortality smr death lung cohort excess exposure cancers
46/54	Cancer, including Prostate, Colorectal and Lung sub-cluster 54	colon cancer rectum colonic bowel colorectal cancers polyps risk patients
46/55	Cancer, including Prostate, Colorectal and Lung sub-cluster 55	cancer renal kidney cell metastatic patients rcc cancers nephrectomy treatment
46/56	Cancer, including Prostate, Colorectal and Lung sub-cluster 56	survival cancer breast patients cancers rates stage diagnosis years colorectal
46/57	Cancer, including Prostate, Colorectal and Lung sub-cluster 57	breast cancer women risk treatment diagnosis age patients screening early
46/58	Cancer, including Prostate, Colorectal and Lung sub-cluster 58	cancer liver primary metastases colorectal hepatic metastatic patients cancers metastasis
46/59	Cancer, including Prostate, Colorectal and Lung sub-cluster 59	trials cancer clinical trial breast phase patients randomized treatment prevention
46/60	Cancer, including Prostate, Colorectal and Lung sub-cluster 60	cancer bone patients breast venous metastases thromboembolism bisphosphonates vte marrow
46/61	Cancer, including Prostate, Colorectal and Lung sub-cluster 61	cancer p53 methylation genes cancers gene epigenetic suppressor mutations tumor
46/62	Cancer, including Prostate, Colorectal and Lung sub-cluster 62	advanced cancer advances breast recent treatment patients management advance therapy
46/63	Cancer, including Prostate, Colorectal and Lung sub-cluster 63	cancer american african education americans society breast screening prostate college
46/64	Cancer, including Prostate, Colorectal and Lung sub-cluster 64	staging cancer stage breast tnm stages patients cancers early classification
46/65	Cancer, including Prostate, Colorectal and Lung sub-cluster 65	cancer pain management patients morphine patient opioid opioids treatment analgesic
46/66	Cancer, including Prostate, Colorectal and Lung sub-cluster 66	cancer testicular nutritional control patients problem sperm parenteral chemotherapy men
46/67	Cancer, including Prostate, Colorectal and Lung sub-cluster 67	exposure cancer asbestos lung radon risk arsenic exposures workers cancers
46/68	Cancer, including Prostate, Colorectal and Lung sub-cluster 68	cancer skin oral prevention cancers melanoma sun patients detection treatment
46/69	Cancer, including Prostate, Colorectal and Lung sub-cluster 69	cancer 5-fu paclitaxel breast docetaxel colorectal metastatic advanced combination chemotherapy
46/70	Cancer, including Prostate, Colorectal and Lung sub-cluster 70	cancer immunotherapy immune viruses immunology immunity immunological immunologic tumor cancers
46/71	Cancer, including Prostate, Colorectal and Lung sub-cluster 71	cancer incidence rates cancers trends age population breast mortality males
46/72	Cancer, including Prostate, Colorectal and Lung sub-cluster 72	cancer registry registries data population based incidence cancers completeness reporting
46/73	Cancer, including Prostate, Colorectal and Lung sub-cluster 73	cancer molecular biology markers breast proteomics clinical technologies proteomic biomarker
46/74	Cancer, including Prostate, Colorectal and Lung sub-cluster 74	telomerase cancer telomere activity telomeres htert cells length senescence human
46/75	Cancer, including Prostate, Colorectal and Lung sub-cluster 75	cancer targeted therapy agents target drugs therapeutic drug molecular development
46/76	Cancer, including Prostate, Colorectal and Lung sub-cluster 76	cancer pulmonary lung pleural effusion patients malignant tuberculosis pericardial chest
46/77	Cancer, including Prostate, Colorectal and Lung sub-cluster 77	cancer apoptosis cell apoptotic bcl-2 death prostate trail induced cancers
46/78	Cancer, including Prostate, Colorectal and Lung sub-cluster 78	cancer cachexia mammary anorexia weight patients loss metabolic nutritional energy
46/79	Cancer, including Prostate, Colorectal and Lung sub-cluster 79	cancer epidemiology epidemiological epidemiologic aspects studies etiology cancers environmental prevention
46/80	Cancer, including Prostate, Colorectal and Lung sub-cluster 80	cancer psychological psychosocial coping distress breast patients support emotional social
46/81	Cancer, including Prostate, Colorectal and Lung sub-cluster 81	cancer patients lymphocyte blood peripheral breast pha cells healthy cell
46/82	Cancer, including Prostate, Colorectal and Lung sub-cluster 82	cancer serum cea patients levels ca breast colorectal carcinoembryonic markers
46/83	Cancer, including Prostate, Colorectal and Lung sub-cluster 83	cancer information community patient physicians breast care physician decision health
46/84	Cancer, including Prostate, Colorectal and Lung sub-cluster 84	cancer risk breast risks assessment factors cancers patients prevention increased
46/85	Cancer, including Prostate, Colorectal and Lung sub-cluster 85	cancer expression breast colorectal cancers prognostic patients metastasis survival cell
46/86	Cancer, including Prostate, Colorectal and Lung sub-cluster 86	cancer human carcinogenic carcinogenesis chemical cancers carcinogen risk humans carcinogenicity
46/87	Cancer, including Prostate, Colorectal and Lung sub-cluster 87	cancer therapy therapies gene breast patients antibodies monoclonal treatment clinical
46/88	Cancer, including Prostate, Colorectal and Lung sub-cluster 88	cancer cells stem cell breast circulating blood cancers metastasis tumour
46/89	Cancer, including Prostate, Colorectal and Lung sub-cluster 89	breast cancer treatment management patients early surgery metastatic diagnosis detection
46/90	Cancer, including Prostate, Colorectal and Lung sub-cluster 90	cancer cervix detection uterine diagnosis early gynecologic cytology uteri cytologic
46/91	Cancer, including Prostate, Colorectal and Lung sub-cluster 91	hyperthermia cancer heat treatment therapy wound heating laser local shock
46/92	Cancer, including Prostate, Colorectal and Lung sub-cluster 92	cancer national institute program center centers control guidelines united states
46/93	Cancer, including Prostate, Colorectal and Lung sub-cluster 93	cancer breast cell growth lines human expression prostate proliferation mcf-7
46/94	Cancer, including Prostate, Colorectal and Lung sub-cluster 94	tissue cancer tissues cancerous breast normal human cancers patients colorectal
46/95	Cancer, including Prostate, Colorectal and Lung sub-cluster 95	cancer compounds activity cytotoxic lines cell cytotoxicity cells anticancer resistance
46/96	Cancer, including Prostate, Colorectal and Lung sub-cluster 96	cancer treatment diagnosis larynx unproven treatments patients rectum laryngeal cancers
46/97	Cancer, including Prostate, Colorectal and Lung sub-cluster 97	cancer stomach larynx pancreas statistics patients cancers spontaneous laryngeal gastrectomy
46/98	Cancer, including Prostate, Colorectal and Lung sub-cluster 98	cancer symposium conference proceedings international war rehabilitation abstracts introduction breast
46/99	Cancer, including Prostate, Colorectal and Lung sub-cluster 99	cancer letter cure editorial oesophageal tongue mouth cancers ovary quackery